Indication
Combined Hyperlipidemia
1 clinical trial
2 products
Clinical trial
Open, Randomized, 2-Group, 2-Period, Fasting, Single-Dose, Crossover Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" of Hanlim Pharm. Co., Ltd. and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" of AstraZeneca Korea Co., Ltd. in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2023-12-07
Product
Crecheck TabletProduct
Crestor